T-Cell
Leukemia - Pipeline Review, H2 2014
Summary
Global Markets
Direct's, 'T-Cell Leukemia - Pipeline Review, H2 2014', provides an overview of
the T-Cell Leukemia's therapeutic pipeline.
This report provides
comprehensive information on the therapeutic development for T-Cell Leukemia,
complete with comparative analysis at various stages, therapeutics assessment
by drug target, mechanism of action (MoA), route of administration (RoA) and
molecule type, along with latest updates, and featured news and press releases.
It also reviews key players involved in the therapeutic development for T-Cell
Leukemia and special features on late-stage and discontinued projects.
Global Markets Direct's
report features investigational drugs from across globe covering over 20
therapy areas and nearly 3,000 indications. The report is built using data and
information sourced from Global Markets Direct's proprietary databases, Company/University
websites, SEC filings, investor presentations and featured press releases from
company/university sites and industry-specific third party sources, put
together by Global Markets Direct's team. Drug profiles/records featured in the
report undergoes periodic updation following a stringent set of processes that
ensures that all the profiles are updated with the latest set of information.
Additionally, processes including live news & deals tracking, browser based
alert-box and clinical trials registries tracking ensure that the most recent
developments are captured on a real time basis.
The report enhances
decision making capabilities and help to create effective counter strategies to
gain competitive advantage. It strengthens R&D pipelines by identifying new
targets and MOAs to produce first-in-class and best-in-class products.
Note*:
Certain sections in the report may be removed or altered based on the
availability and relevance of data for the indicated disease.
Scope
- The report provides a
snapshot of the global therapeutic landscape of T-Cell Leukemia
- The report reviews
key pipeline products under drug profile section which includes, product
description, MoA and R&D brief, licensing and collaboration details &
other developmental activities
- The report reviews
key players involved in the therapeutics development for T-Cell Leukemia and
enlists all their major and minor projects
- The report summarizes
all the dormant and discontinued pipeline projects
- A review of the
T-Cell Leukemia products under development by companies and
universities/research institutes based on information derived from company and
industry-specific sources
- Pipeline products
coverage based on various stages of development ranging from pre-registration
till discovery and undisclosed stages
- A detailed assessment
of monotherapy and combination therapy pipeline projects
- Coverage of the
T-Cell Leukemia pipeline on the basis of target, MoA, route of administration
and molecule type
- Latest news and deals
relating related to pipeline products
Reasons
to buy
- Provides
strategically significant competitor information, analysis, and insights to
formulate effective R&D development strategies
- Identify emerging
players with potentially strong product portfolio and create effective
counter-strategies to gain competitive advantage
- Develop strategic
initiatives by understanding the focus areas of leading companies
- Identify and
understand important and diverse types of therapeutics under development for
T-Cell Leukemia
About
Radiant Insights
Radiant Insights is a
platform for companies looking to meet their market research and business
intelligence requirements. We assist and facilitate organizations and
individuals procure market research reports, helping them in the decision
making process. We have a comprehensive collection of reports, covering over 40
key industries and a host of micro markets. In addition to over extensive
database of reports, our experienced research coordinators also offer a host of
ancillary services such as, research partnerships/ tie-ups and customized
research solutions.
For
more information visit, Radiant
Insights
Contact
Details:
Michelle Thoras
Corporate Sales
Specialist, USA
Radiant Insights, Inc
Phone: 1-415-349-0054
Toll Free:
1-888-202-9519
No comments:
Post a Comment